Toll-like receptors (TLRs) are a class of proteins that play a crucial role in the innate immune system. TLR agonists are molecules that stimulate these receptors, thereby enhancing the immune response. These agonists can be natural or synthetic and are being investigated for their potential to boost vaccine efficacy, combat infectious diseases, and treat cancer.
